Phibro Animal Health reported $546.48M in Current Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Align Technology ALGN:US $ 2376.8M 103.96M
Ani Pharmaceuticals ANIP:US $ 322.4M 21M
Aurora Cannabis Inc ACB:CN 696.63M 92.19M
Bristol Myers Squibb BMY:US $ 30186M 65M
Canopy Growth Corp WEED:CN C$ 1.59B 143.83M
Corcept Therapeutics CORT:US $ 419.04M 30.82M
Depomed DEPO:US $ 117.39M 7.73M
Eli Lilly And LLY:US $ 17115.2M 150.5M
Endo International Ordinary Shares ENDP:US $ 2199.9M 292.89M
Henry Schein HSIC:US $ 3789M 41M
Idexx Laboratories IDXX:US $ 1042.82M 46.95M
JAZZ PHA JAZZ:US $ 2590.83M 89.98M
Knight Therapeutics Inc GUD:CN C$ 320.35M 10.66M
Lannett LCI:US $ 318.7M 15.91M
Nektar Therapeutics NKTR:US $ 665.54M 67.92M
Pacira Pharmaceuticals PCRX:US $ 526.21M 140.81M
Phibro Animal Health PAHC:US $ 546.48M 37.87M
Prestige Brands PBH:US $ 324.62M 31.35M
Supernus Pharmaceuticals SUPN:US $ 625.12M 56.6M
Teva Pharmaceutical Industries TEVA:US $ 12164M 287M
Zoetis ZTS:US $ 6651M 186M